Syensqo (SYENS) - Total Liabilities
Based on the latest financial reports, Syensqo (SYENS) has total liabilities worth €5.47 Billion EUR (≈ $6.39 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Syensqo - Total Liabilities Trend (2020–2025)
This chart illustrates how Syensqo's total liabilities have evolved over time, based on quarterly financial data. See SYENS net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Syensqo Competitors by Total Liabilities
The table below lists competitors of Syensqo ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Janus Henderson Group PLC
NYSE:JHG
|
USA | $2.08 Billion |
|
Dino Polska SA
WAR:DNP
|
Poland | zł6.50 Billion |
|
Western Alliance Bancorporation
NYSE:WAL
|
USA | $84.83 Billion |
|
TongKun Group Co Ltd
SHG:601233
|
China | CN¥80.13 Billion |
|
Vietnam Prosperity Joint Stock Commercial Bank
VN:VPB
|
Vietnam | ₫1185.41 Trillion |
|
Multi Commodity Exchange of India Limited
NSE:MCX
|
India | Rs21.46 Billion |
|
NH Investment & Securities Co Ltd
KO:005940
|
Korea | ₩72.54 Trillion |
|
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653
|
China | CN¥2.82 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down Syensqo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SYENS company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Syensqo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Syensqo (2020–2025)
The table below shows the annual total liabilities of Syensqo from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €4.89 Billion ≈ $5.72 Billion |
-7.46% |
| 2024-06-30 | €5.29 Billion ≈ $6.18 Billion |
-39.15% |
| 2023-06-30 | €8.69 Billion ≈ $10.15 Billion |
+4.11% |
| 2022-06-30 | €8.34 Billion ≈ $9.75 Billion |
+0.60% |
| 2021-06-30 | €8.29 Billion ≈ $9.70 Billion |
-11.75% |
| 2020-06-30 | €9.40 Billion ≈ $10.99 Billion |
-- |
About Syensqo
Syensqo SA/NV engages in the research, development, and production of advanced materials for industrial and consumer applications worldwide. It operates through Materials, Consumer & Resources segments. The company offers amine ether, amines, fatty amines, and specialty amines; antioxidants and stabilizers; composites; flavors and fragrances, such as vanillin, ethylvanillin, natural vanillin, and… Read more